Latest return on equity
MapLight Therapeutics Return on equity
Direct answer
MapLight Therapeutics's return on equity is -111.55%.
The verified market snapshot reports -111.55%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free MapLight Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -111.55%
Explore related company data
View MapLight Therapeutics's market capitalizationView MapLight Therapeutics's price-to-book ratioView MapLight Therapeutics's dividend yieldView MapLight Therapeutics's 52-week price rangeView MapLight Therapeutics's profit marginView MapLight Therapeutics's debt-to-equity ratioView all MapLight Therapeutics key metricsReturn to MapLight Therapeutics profile